Metagenomi Therapeutics reported net income of -$27.56M for the quarter ended Jun 2026. This income statement covers 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 3.40M | 3.40M | 3.40M | 3.40M | 21.14M | 37.46M | 37.43M | 37.42M | 37.38M | 37.53M | 37.55M | 37.62M | 37.65M | 37.78M |
| Revenue & cost | ||||||||||||||
| Revenue | 8.66M | 11.34M | 12.36M | 12.40M | 11.16M | 20.01M | 11.51M | 9.61M | 4.13M | 8.51M | 8.66M | 3.91M | 1.25M | |
| Operating items | ||||||||||||||
| Research & DevelopmentR&D | 20.13M | 22.68M | 26.84M | 24.75M | 31.44M | 28.32M | 26.26M | 23.16M | 25.14M | 22.51M | 25.28M | 21.50M | 19.30M | 22.51M |
| Selling, General & AdministrativeSG&A | 6.46M | 6.62M | 7.92M | 7.84M | 8.75M | 8.55M | 7.64M | 7.07M | 6.80M | 6.99M | 6.21M | 6.78M | 6.54M | 6.00M |
| Operating ExpensesOpex | 26.59M | 29.30M | 34.76M | 32.59M | 40.19M | 36.87M | 33.90M | 30.24M | 31.95M | 29.50M | 31.50M | 28.28M | 25.84M | 28.52M |
| Operating IncomeOp. Inc | -17.94M | -17.96M | -22.39M | -20.20M | -29.03M | -16.86M | -22.38M | -20.62M | -27.82M | -20.99M | -22.84M | -24.37M | -24.59M | -28.77M |
| EBIT | -17.94M | -17.96M | -22.39M | -20.20M | -29.03M | -16.86M | -22.38M | -20.62M | -27.82M | -20.99M | -22.84M | -24.37M | -24.59M | -28.77M |
| Non-operating items | ||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 4.00M | 3.97M | 3.87M | 3.63M | 3.93M | 3.98M | 3.62M | 3.20M | 2.89M | 2.48M | 2.21M | 1.88M | 1.54M | 1.26M |
| Other Non Operating IncomeOther Non Op Inc. | -0.00M | 0.02M | -0.09M | -0.00M | -0.05M | -0.05M | -0.06M | -0.05M | -0.01M | -0.07M | -0.00M | -0.01M | -0.00M | 0.04M |
| Non Operating IncomeNon Op. Inc. | 4.00M | 6.85M | 3.78M | 3.63M | 3.88M | 3.92M | 1.50M | -3.98M | 2.88M | 1.12M | 2.21M | 1.87M | 1.54M | 1.29M |
| Net income details | ||||||||||||||
| EBT | -13.94M | -11.11M | -18.61M | -16.57M | -25.15M | -12.94M | -20.88M | -24.61M | -24.94M | -19.86M | -20.63M | -22.49M | -23.05M | -27.48M |
| Tax ProvisionsTaxes | -2.20M | 1.90M | 1.21M | 2.73M | -2.20M | -2.11M | -1.21M | 0.10M | 0.04M | -0.23M | -18.37M | 0.01M | ||
| Profit After TaxPAT | -16.13M | -13.01M | -19.82M | -19.21M | -25.15M | -10.74M | -18.77M | -23.40M | -25.04M | -20.16M | -20.39M | -22.64M | -23.06M | -27.56M |
| Income from Continuing OperationsIncome (Continuing) | -11.74M | -13.01M | -19.82M | -19.29M | -25.15M | -10.74M | -18.77M | -23.40M | -25.04M | -19.91M | -20.39M | -4.12M | -23.06M | -27.48M |
| Consolidated Net IncomeConsol Net Inc. | -11.74M | -13.01M | -19.82M | -19.29M | -25.15M | -10.74M | -18.77M | -23.40M | -25.04M | -19.91M | -20.39M | -4.12M | -23.06M | -27.48M |
| Income towards Parent CompanyParent Net Inc | -11.74M | -13.01M | -19.82M | -19.29M | -25.15M | -10.74M | -18.77M | -23.40M | -25.04M | -19.91M | -20.39M | -4.12M | -23.06M | -27.48M |
| Net Income towards Common StockholdersNet Income | -16.13M | -13.01M | -19.82M | -19.29M | -25.15M | -10.74M | -18.77M | -23.40M | -25.04M | -19.91M | -20.39M | -22.53M | -23.06M | -27.48M |
| Additional items | ||||||||||||||
| EPS (Basic) | -4.74 | -3.82 | -5.82 | -5.67 | -1.19 | -0.29 | -0.51 | -0.71 | -0.68 | -0.54 | -0.55 | -0.60 | -0.61 | -0.73 |
| EPS (Diluted) | -4.74 | -3.82 | -5.82 | -5.67 | -1.19 | -0.29 | -0.51 | -0.71 | -0.68 | -0.54 | -0.55 | -0.60 | -0.61 | -0.73 |
| Shares Outstanding | 3.40M | 3.40M | 3.40M | 3.40M | 21.14M | 36.63M | 36.77M | 33.03M | 37.02M | 37.16M | 37.35M | 37.25M | 37.58M | 37.66M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 3.40M | 3.40M | 3.40M | 3.40M | 21.14M | 36.63M | 36.77M | 33.03M | 37.02M | 37.16M | 37.35M | 37.25M | 37.58M | 37.66M |
| EBITDA | -17.94M | -17.96M | -22.39M | -20.20M | -29.03M | -16.86M | -22.38M | -20.62M | -27.82M | -20.99M | -22.84M | -24.37M | -24.59M | -28.77M |
| Tax Rate | 15.76 | -17.08 | -6.48 | -16.45 | 17.00 | 10.09 | 4.91 | -0.39 | -0.22 | 1.13 | 81.68 | -0.04 |